ICON CLINICAL RESEARCH (U.K.) NO. 6 LIMITED Financials
- Company number
- 09743789Copy
Copy - Registered office
- 3rd Floor, North & South Wings 100 Longwater Avenue, Green Park, Reading, Berkshire RG2 6GP
- Incorporated
- 21/08/2015
Company snapshot
- Status
- Active
- Employees
- 2 (2024)
- Latest financial data
- 2024
- Accounts type
- Full
Financial highlights
Latest reported figures. Okredo holds filed data for 2021–2024.
Net Assets
No changevs 20232023: £32.15M
Total Assets
-0.07%vs 20232023: £32.17M
Cash in Bank
-14.84%vs 20232023: £166.10K
Total Liabilities
-66.87%vs 20232023: £30.60K
Employees
-1vs 20232023: 3
In 2024, ICON CLINICAL RESEARCH (U.K.) NO. 6 LIMITED reported net assets of £32.14M. The same filing shows total assets of £32.15M, cash in bank of £141.44K and total liabilities of £10.14K. Reported headcount was 2 in 2024. Cash in Bank fell from £166.10K in 2023 to £141.44K in 2024 (-14.84%). Okredo holds filed figures for 2021–2024; the table below lists every reported indicator by year. See every reported indicator by year.
Financial performance
Pick a measure to see how it has moved across the reported years, with the year-on-year change beneath it.
Net Assets
No changefrom £32.15M in 2023Year-on-year change
Net Assets as filed for 2021–2024. Every figure in this chart is also in the financial history table.
3-year financial trend (2022–2024)
How the figures ICON CLINICAL RESEARCH (U.K.) NO. 6 LIMITED filed moved across the three reported years 2022, 2023 and 2024 — measured end to end rather than year on year.
Net Assets
+20.6%vs 2022+9.8% a year compound (CAGR)
Cash in Bank
+776%vs 2022+196% a year compound (CAGR)
Total Assets
+20.7%vs 2022+9.8% a year compound (CAGR)
Total Liabilities
+65.1%vs 2022+28.5% a year compound (CAGR)
Employees
-33.3%vs 2022-1Biggest increase
Cash in Bank+776%
£16.14K in 2022 to £141.44K in 2024
Biggest decrease
Employees-33.3%
3 in 2022 to 2 in 2024
ICON CLINICAL RESEARCH (U.K.) NO. 6 LIMITED's filings pull in both directions between 2022 and 2024. The steepest rise came in cash in bank, pointing to a more liquid cash position, set against a fall in employee numbers, pointing to a smaller workforce. See the full year-by-year figures.
Ratios from the filed figures
Calculated from ICON CLINICAL RESEARCH (U.K.) NO. 6 LIMITED's own reported amounts, each shown against the year it was derived from — nothing here is estimated or industry-averaged.
- Net assets to total assets
- 99.97%2024
- Liabilities to total assets
- 0.03%2024
- Cash to liabilities
- 1,395.02%2024
- Cash to total assets
- 0.44%2024
Reported net assets divided by reported total assets, for the latest year both were filed. Shows how much of the asset base is not financed by liabilities.
Total liabilities divided by reported total assets, for the latest year both were available. Shows how much of the asset base is funded by obligations.
Reported cash in bank divided by total liabilities for the same year. Shows what share of outstanding obligations the reported cash balance would cover.
Reported cash in bank divided by reported total assets, for the latest year both were filed.
Financial history
Every indicator Okredo tracks, year by year.
Reported financial indicators for ICON CLINICAL RESEARCH (U.K.) NO. 6 LIMITED by year. Amounts are as filed; a dash means the figure was not reported for that year.
| Indicator | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Net Assets£ | 25.50M | 26.64M | 32.15M | 32.14M |
| Total Assets£ | 25.51M | 26.65M | 32.17M | 32.15M |
| Cash in Bank£ | 7.09K | 16.14K | 166.10K | 141.44K |
| Total Liabilities£ | 7.20K | 6.14K | 30.60K | 10.14K |
| Employees | 3 | 3 | 3 | 2 |
ICON CLINICAL RESEARCH (U.K.) NO. 6 LIMITED financials: frequently asked questions
Answered from this company's own filed figures.
Has ICON CLINICAL RESEARCH (U.K.) NO. 6 LIMITED filed financial statements?
Yes. Okredo holds filed figures for ICON CLINICAL RESEARCH (U.K.) NO. 6 LIMITED covering 2021–2024, across 5 reported indicators. The most recent reported year is 2024.
What net assets did ICON CLINICAL RESEARCH (U.K.) NO. 6 LIMITED report in 2024?
ICON CLINICAL RESEARCH (U.K.) NO. 6 LIMITED reported net assets of £32.14M for 2024. That compares with £32.15M in 2023.
What total assets did ICON CLINICAL RESEARCH (U.K.) NO. 6 LIMITED report in 2024?
ICON CLINICAL RESEARCH (U.K.) NO. 6 LIMITED reported total assets of £32.15M for 2024. That compares with £32.17M in 2023, a change of -0.07%.
What cash in bank did ICON CLINICAL RESEARCH (U.K.) NO. 6 LIMITED report in 2024?
ICON CLINICAL RESEARCH (U.K.) NO. 6 LIMITED reported cash in bank of £141.44K for 2024. That compares with £166.10K in 2023, a change of -14.84%.
How many people does ICON CLINICAL RESEARCH (U.K.) NO. 6 LIMITED employ?
ICON CLINICAL RESEARCH (U.K.) NO. 6 LIMITED reported 2 employees in 2024, compared with 3 in 2023.
How have ICON CLINICAL RESEARCH (U.K.) NO. 6 LIMITED financials changed over the last 3 years?
Between 2022 and 2024, ICON CLINICAL RESEARCH (U.K.) NO. 6 LIMITED's net assets rose by 20.6%, cash in bank rose by 776%, total assets rose by 20.7% and total liabilities rose by 65.1%. Net assets compounded at 9.8% a year across the two years to 2024, from £26.64M to £32.14M. Reported headcount went from 3 in 2022 to 2 in 2024 (-1).
Which years of ICON CLINICAL RESEARCH (U.K.) NO. 6 LIMITED financial data are available?
Okredo holds reported figures for the years 2021, 2022, 2023, 2024. Where an indicator was not reported for a given year, the financial history table shows a dash rather than a value.